Weiguo Lu is a Professor at UT Southwestern Medical Center. He obtained his BS and MS in Nuclear Physics from Peking University (1990-1997), MS and Ph.D. in Medical Physics from the University of Wisconsin-Madison (1997-2001), and MS in Computer Sciences from University of Wisconsin-Madison (2000-2001). From 2001 to 2011, he worked as a Director of Innovation and Physics at TomoTherapy Inc. From 2011 to
2014, he worked as a Director of Research at 21st Century Oncology. His research interests are automatic and intelligent quality assurance in radiotherapy, medical image processing, novel image guidance and delivery, and online and real-time radiotherapy planning.
Dr. Hao Jiang is the Chief Executive Officer at NeuralRad LLC, and he leads a team of talented engineers and scientists who are developing cutting-edge solutions for radiation oncology using artificial intelligence. With over 6 years of experience in this role, he has successfully launched multiple products and services that improve the quality, efficiency, and safety of cancer treatment planning, workflow, and delivery. Before that, he was a Chief Executive Officer at IntelliOS Ltd. focusing on implementing Artificial Intelligence in radiation oncology in terms of treatment planning, workflow, auto-plan, and hospital information systems and a Detector Imaging Scientist at Bruker AXS. He holds a Ph.D. in Nuclear Engineering from the University of Michigan, where he developed novel methods and algorithms for detector imaging.
Strahinja Stojadinovic is a licensed medical physicist in the state of Texas. In addition, he is a co-director for the UT Southwestern Gamma Knife Training Program, a comprehensive course for both new users and experienced professionals upgrading to the Gamma Knife Icon. He graduated from the University of Belgrade in 1998. His specialty is Gamma Knife and GammaPod clinical service. He also teaches selected topics in radiation physics as a part of the educational lecture series for the Radiation Oncology Medical Residency Program as well as for the Radiological Physics Certificate Program.
Zabi Wardak is an Associate Professor, a Chief of Central Nervous System Radiation Oncology Service, and a Medical Director of the Gamma Knife Program. He earned his medical degree from SUNY Upstate Medical University in New York and completed his residency training in radiation oncology at UT Southwestern Medical Center, where he served as Chief Resident. He has additional advanced training and certification in the use of Gamma Knife stereotactic radiosurgery (SRS) and CyberKnife stereotactic radiotherapy. He specializes in treating benign and malignant brain and spinal cord tumors with a focus on stereotactic radiosurgery. His research interests include advancing the treatment of brain metastases with radiosurgery and computing improvements in the field of radiation oncology.
Tu Dan graduated from the University of Florida with degrees in microbiology and psychology, and he continued at UF and earned his medical degree with honors in research. During medical school, he spent significant time at the National Institutes of Health developing his interests in cancer research and, between his third and fourth years, was selected to participate in the prestigious NIH Clinical Research Training Program (CRTP). He completed an internship in internal medicine and a residency in radiation oncology at Thomas Jefferson University in Pennsylvania. While in residency, he was awarded a Resident Seed Grant from the American Society of Radiation Oncology (ASTRO). He has been the lead or contributing author of numerous cancer research papers published in peer-reviewed medical journals. He arrived at UT Southwestern in 2016 and became a member of the dedicated central nervous system (CNS) cancer team. He is a health and fitness advocate who takes a holistic approach to treatment and has published several manuscripts examining the role of diet in the development and treatment of cancer. He believes that in addition to standard treatments, other factors including diet, exercise, and psychological well-being all play important roles in the care of cancer patients.
Robert Timmerman is a Professor and a Chair of the Department of Radiation Oncology, as well as a Professor of Neurosurgery, and holds the Effie Marie Cain Distinguished Chair in Cancer Therapy Research. After earning a master’s degree in reactor physics, he completed medical school in his home state of South Dakota, followed by a residency in radiation oncology at The Johns Hopkins Hospital. One of his greatest successes was the development of a trial that demonstrated inoperable lung cancer patients treated with SAbR could have considerably higher tumor control than with conventional radiation while still mostly avoiding toxicity. His treatment method has become the new standard of care for this class of patients. He currently directs training courses in stereotactic radiotherapy, both at UT Southwestern and nationally for members of the National Radiation Therapy Oncology Group. He is a highly sought-after guest speaker and has authored or co-authored numerous peer-reviewed articles and textbooks. In 2018, he was named a Super Doctor by Texas Monthly.
Dr. Lei Wang is a Clinical Professor in Radiation Oncology—Radiation Physics at the Department of Radiation Oncology, Stanford University. Her clinical duty is to provide physics support and assure the quality and safety of radiation treatment. She does clinical research on Linac and Cyberknife-based SRS and SBRT which includes: small field dosimetry, machine and patient quality assurance, treatment planning, etc.; new QA tool and methodology development and new treatment technology implementation to keep high standards in patient care. She holds a B.S. in Physics gained from Tsinghua University, an M.S. in Computer Science and a Ph.D. in Physics at the University at Albany.
Dr. Cynthia Chuang is a Clinical Professor in Radiation Oncology—Radiation Physics at the Department of Radiation Oncology, Stanford University. She obtained a B.S. in Bioelectrical Engineering (6-1B), an M.S. in Nuclear Engineering (NMR Spectroscopy) and a Ph.D. in Nuclear Engineering (Boron Neutron Capture Therapy) at the Massachusetts Institute of Technology and also an M.S. in Bioengineering at the University of Pennsylvania. In 2011, she completed a Postdoctoral Fellowship (Peregrine Project) at the Lawrence Livermore National Laboratory. And in 2003, She completed a Medical Physics Residency at the University of California, (joint 3.5-year postdoctoral and residency program). She received the Fairchild Award for Young Researchers, from the International Society for Neutron Capture Therapy (1998) and the Travel Grant Award Recipient, AAPM (2004).
Dr. Gregory Szalkowski is a Clinical Assistant Professor in Radiation Oncology—Radiation Physics at the Department of Radiation Oncology, Stanford University. He obtained a B.S. in Nuclear and Radiological Engineering, an M.S. in Health/Medical Physics and a Ph.D. in Health/Medical Physics at Georgia Institute of Technology. He was an Interim Lab Manager at Georgia Institute of Technology handling management of the Radiological Science and Engineering Laboratory (RSEL) at Georgia Tech, including a Varian iX clinac. His clinical specialties include robotic radiosurgery; stereotactic body radiation therapy (SBRT); and treatment planning. His current research focus is on automating treatment planning for spine and brain cases treated using the CyberKnife system.
Erqi Pollom is an Associate Professor of Radiation Oncology (Radiation Therapy) and, by courtesy, of Neurosurgery. She obtained her BS in Chemical Engineering from the Massachusetts Institute of Technology in 2008 and her MD in Medicine from the University of Michigan Medical School in 2012. She was awarded Academic Distinction from the University of Michigan Medical School (2012), the 97th Annual Meeting Travel Award from the American Radium Society (2015), and the 99th Annual Meeting Travel Award from the American Radium Society (2017). She practices at Stanford Health Care Stanford Medicine Children's Health Stanford Medicine Partners.
Elham Rahimy is a radiation oncologist who treats patients with brain, spine, and gastrointestinal tumors. She received her medical training at Yale, followed by a residency in radiation oncology at Stanford. She is a clinical assistant professor with the Stanford School of Medicine Department of Radiation Oncology. She specializes in treating several types of cancer, including brain tumors, such as glioma and glioblastoma, spine tumors, metastatic disease, and gastrointestinal cancer, such as rectal cancer and pancreatic cancer. She is credentialed for CyberKnife Radiosurgery. She is also actively involved in radiation oncology research and clinical trials. Her interests include improving patient and resident education and enhancing patient quality of life and survivorship. Her research has been published in a variety of journals. She is also the current radiation oncology medical student clerkship director.
Scott Soltys is a Professor of Radiation Oncology (Radiation Therapy) and, by courtesy, of Neurosurgery. He is a Member of the Stanford Cancer Institute. he obtained a BS in Cell and Structural Biology from the University of Illinois in 1995 and an MD in Medicine from the University of Michigan in 2000. In 2001, he started his Internship at Oakwood Healthcare System, and in 2006, he obtained his Board Certification in Radiation Oncology from the American Board of Radiology. In 2005, he became the Residency at the Stanford University Radiation Oncology Residency.
Xuejun Gu is an Associate Professor and Director of Translational Research at the Radiation Oncology Department at Stanford University. She is an author on more than 100 peer-reviewed publications, a co-inventor on many issued and pending patents, and a co-investigator or principal investigator on NIH and corporate grants. She is on the editorial boards of several journals in medical physics and medical imaging. Her research has been focused on artificial intelligence in medicine, medical imaging and image analysis, and treatment planning. With the research emphasizing clinical application, she has made unique and significant contributions to translating home-developed software platforms into the clinic and pre-clinic.
